Applying to the Anesthesiology Residency

Application Process

The Anesthesiology Residency Program at UMass Chan Medical School-Baystate participates in the ERAS Program for the residency application process. For information about an application for our Anesthesiology Program, visit the ERAS website.

  • Applications received by mail will not be accepted.
  • The deadline for receipt of the ERAS application is December 31.
  • Upon receipt of the application, it will be reviewed and an invitation for an interview will be extended by e-mail to qualified applicants.
  • Interviews are offered based on academic performance, USMLE or Comlex scores and letters of recommendation.

Application Requirements

  • The USMLE Step 2 score should be at least 230, while Comlex 1 & 2 should be above 550 to be considered for an interview
  • We only accept applications through ERAS: include 3 letters of recommendation (and one from an anesthesiologist), Dean's letter, medical school transcripts, copies of USMLE/COMLEX scores, and a photo.
  • If you had spent time in another training program, we will need a letter of recommendation from the Program Director.
  • All resident applicants must fulfill Baystate's Resident & Fellow Appointment Requirements.

International Medical School Graduates

In addition to the above, the following are also required:

  • A current ECFMG certificate, valid indefinitely
  • Clinical experience is required within the last two years. Note: Observerships and Externships DO NOT fulfill this requirement.
  • Baystate Medical Center prefers to sponsor J1 visas; however, with the promotion of the Program Director and under exceptional circumstances, the Designated Institutional Official will review H1B applications on a case by case basis.

Interviews

Virtual Interviewing

Consistent with recommendations from the AAMC and the ACGME, UMass Chan-Baystate GME programs will conduct interviews virtually for all applicants.

Please feel free to call us at 413-794-4326 or 800-959-4233 if you have any questions.

We look forward to hearing from you!

Back to Top